000 01206 a2200337 4500
005 20250515193837.0
264 0 _c20110408
008 201104s 0 0 eng d
022 _a1559-131X
024 7 _a10.1007/s12032-009-9349-y
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCandelaria, M
245 0 0 _aPharmacogenetics and pharmacoepigenetics of gemcitabine.
_h[electronic resource]
260 _bMedical oncology (Northwood, London, England)
_cDec 2010
300 _a1133-43 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntimetabolites, Antineoplastic
_xtherapeutic use
650 0 4 _aDeoxycytidine
_xanalogs & derivatives
650 0 4 _aEpigenomics
650 0 4 _aHumans
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aPharmacogenetics
650 0 4 _aGemcitabine
700 1 _ade la Cruz-Hernández, E
700 1 _aPérez-Cárdenas, E
700 1 _aTrejo-Becerril, C
700 1 _aGutiérrez-Hernández, O
700 1 _aDueñas-González, A
773 0 _tMedical oncology (Northwood, London, England)
_gvol. 27
_gno. 4
_gp. 1133-43
856 4 0 _uhttps://doi.org/10.1007/s12032-009-9349-y
_zAvailable from publisher's website
999 _c19289546
_d19289546